MEDICO vs ORTINGLOBE: Stock Comparison

MEDICO REMEDIES vs ORTIN GLOBALUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

MEDICO REMEDIES is the larger company by market capitalisation. MEDICO REMEDIES shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDICO leads 9; ORTINGLOBE leads 1 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDICOORTINGLOBE

Valuation lens

What price are you paying?

Market CapContext only
₹329 Cr
₹12 Cr
P/E RatioSame reading
26.66x
P/B RatioSame reading
4.86x
EPSMEDICO has the higher reading
₹0.3
₹-0.42
Book ValueContext only
₹9.1
₹1.52
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MEDICO is the larger company
₹329 Cr vs ₹12 Cr
EPS
MEDICO has higher earnings per share
₹0.3 vs ₹-0.42
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs -76.86%
EPS Growth (TTM YoY)
MEDICO has faster EPS growth
36.5% vs 0%
Qtr Sales Growth
ORTINGLOBE has stronger quarterly sales growth
-66.28% vs -66.37%
Qtr Profit Growth
MEDICO has stronger quarterly profit growth
-80.8% vs -3,533.33%
ROE
MEDICO has a higher ROE
17.38% vs -59.85%
ROCE
MEDICO has a higher ROCE
15.61% vs -44.08%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICOORTINGLOBE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICOORTINGLOBE
Live Price₹39.87₹15.67
Day Change0.94%4.33%
Volume52,9329,743
52-Week High₹56.88₹21.3
52-Week Low₹30.22₹11
Distance from 52W High-29.91%-26.43%

Valuation

MetricMEDICOORTINGLOBE
Market Cap₹329 Cr₹12 Cr
P/E Ratio26.66x
P/B Ratio4.86x
EPS₹0.3₹-0.42
Book Value₹9.1₹1.52
Dividend Yield0%0%

Growth

MetricMEDICOORTINGLOBE
Revenue Growth (TTM YoY)37.5%-76.86%
EPS Growth (TTM YoY)36.5%0%
Qtr Sales Growth-66.37%-66.28%
Qtr Profit Growth-80.8%-3,533.33%

Profitability & Leverage

MetricMEDICOORTINGLOBE
ROE17.38%-59.85%
ROCE15.61%-44.08%
Net Margin6.36%-529.87%
Operating Margin9.63%-717.61%
Debt to Equity0.25x0.81x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMEDICOORTINGLOBE
Promoter Holding61.38%1.23%
FII Holding0.08% 0.05 pp1.8% 0.12 pp
DII Holding0%0%
Public Holding38.54% 0.05 pp96.96% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MEDICO REMEDIES and ORTIN GLOBAL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.